Lofepramine
Lofepramine is a tricyclic antidepressant used to treat depressive disorders, particularly major depressive episodes. It works by inhibiting the reuptake of noradrenaline and, to a lesser extent, serotonin, increasing the availability of these neurotransmitters in the brain. It is available as oral tablets, with availability and approved strengths varying by country. Common side effects include dry mouth, constipation, nausea, dizziness, sweating, and blurred vision. Important precautions include monitoring for mood changes, suicidal thoughts, cardiac rhythm disturbances, and symptoms of mania, particularly during treatment initiation or dose changes. Lofepramine should be used under medical supervision, and the dose should be reduced gradually rather than stopped abruptly.
Lofepramine was historically used as a respiratory medicine for the symptomatic management of certain respiratory conditions. Its former uses included:
is okay
The import of medicines into India is regulated by the Central Drugs Standard Control Organisation (CDSCO) under the Drugs and Cosmetics Act, 1940, and the Drugs and Cosmetics Rules, 1945. The regulatory requirements depend on whether the product is an active pharmaceutical ingredient (API), a finished formulation, or an unapproved medicine intended for an individual patient's treatment.
Primeera Healthcare Private Limited can provide import coordination and pharmaceutical documentation assistance for Lofepramine, subject to confirmation of its current regulatory status and eligibility for import into India.
The export of Lofepramine from India is subject to applicable requirements under the Drugs and Cosmetics Act, 1940, the Drugs and Cosmetics Rules, 1945, and relevant export, customs, and destination-country regulations. Documentation requirements depend on whether the product is an active pharmaceutical ingredient (API), a finished pharmaceutical formulation, or a medicine intended for a specific market. Export eligibility and destination-country requirements must be verified before shipment.
Primeera Healthcare Private Limited can provide pharmaceutical export documentation assistance, regulatory coordination, and shipping support for Lofepramine, subject to confirmation of its export eligibility under applicable Indian regulations and the import requirements of the destination country.
If you have any questions or need any help, contact our Support Team. We will get in touch with you within 24 hours from Monday to Friday between 9:00 and 10:00 CET.
All Trademarks and Brands that appear on the website belong to their respective owners. Primeera Healthcare does not lay any claim on them; we only provide information.
